These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 9780340)

  • 41. Hypertrophic cardiomyopathy: prognostic factors and survival analysis in 128 Egyptian patients.
    El-Saiedi SA; Seliem ZS; Esmail RI
    Cardiol Young; 2014 Aug; 24(4):702-8. PubMed ID: 23895893
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Myocardial bridging of the left anterior descending coronary artery without relation to the site of hypertrophy in hypertrophic cardiomyopathy.
    Doi YL; Yamada M; Hamashige N; Yonezawa Y; Odawara H; Ozawa T
    Eur Heart J; 1987 Jul; 8(7):793-5. PubMed ID: 3653130
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nonsustained ventricular tachycardia.
    Katritsis DG; Zareba W; Camm AJ
    J Am Coll Cardiol; 2012 Nov; 60(20):1993-2004. PubMed ID: 23083773
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hemodynamic effects of myocardial bridging in patients with hypertrophic cardiomyopathy.
    Sharzehee M; Chang Y; Song JP; Han HC
    Am J Physiol Heart Circ Physiol; 2019 Dec; 317(6):H1282-H1291. PubMed ID: 31674812
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Angiographic prevalence of myocardial bridging.
    Cay S; Oztürk S; Cihan G; Kisacik HL; Korkmaz S
    Anadolu Kardiyol Derg; 2006 Mar; 6(1):9-12. PubMed ID: 16524793
    [TBL] [Abstract][Full Text] [Related]  

  • 46. J wave is associated with increased risk of sudden cardiac arrest in patients with hypertrophic cardiomyopathy.
    Li Y; Mao J; Yan Q; Qi S; Liu X; Tan C; Zhang Y; Shi L; Tian Y; Wu Y; Zeng Y; Wang J; Chu J; Ma C; Liu X; Yang X
    J Int Med Res; 2013 Aug; 41(4):1281-90. PubMed ID: 23867451
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cardiac arrest upon induction of anesthesia in children with cardiomyopathy: an analysis of incidence and risk factors.
    Lynch J; Pehora C; Holtby H; Schwarz SM; Taylor K
    Paediatr Anaesth; 2011 Sep; 21(9):951-7. PubMed ID: 21736663
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Myocardial bridges: A review.
    Loukas M; Von Kriegenbergh K; Gilkes M; Tubbs RS; Walker C; Malaiyandi D; Anderson RH
    Clin Anat; 2011 Sep; 24(6):675-83. PubMed ID: 21751254
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term outcome and prognostic determinants in children with hypertrophic cardiomyopathy.
    Yetman AT; Hamilton RM; Benson LN; McCrindle BW
    J Am Coll Cardiol; 1998 Dec; 32(7):1943-50. PubMed ID: 9857876
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Myocardial bridging as a common phenotype of hypertrophic cardiomyopathy has no effect on prognosis.
    Tian T; Wang YL; Wang JZ; Sun K; Zou YB; Zhang WL; Zhu L; Shen H; Hui RT; Zhou XL; Song L
    Am J Med Sci; 2014 Jun; 347(6):429-33. PubMed ID: 24270076
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cardiac dysrhythmias in children with idiopathic dilated or hypertrophic cardiomyopathy.
    Müller G; Ulmer HE; Hagel KJ; Wolf D
    Pediatr Cardiol; 1995; 16(2):56-60. PubMed ID: 7540289
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Usefulness of MRI to demonstrate the mechanisms of myocardial ischemia in hypertrophic cardiomyopathy with myocardial bridge.
    Thomson V; Botnar R; Croisille P
    Cardiology; 2007; 107(3):159-64. PubMed ID: 16888385
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population.
    Spirito P; Chiarella F; Carratino L; Berisso MZ; Bellotti P; Vecchio C
    N Engl J Med; 1989 Mar; 320(12):749-55. PubMed ID: 2646539
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Wearable cardioverter-defibrillator as bridging to ICD in pediatric hypertrophic cardiomyopathy with myocardial bridging - a case report.
    Kurath-Koller S; Sallmon H; Scherr D; Bisping E; Burmas A; Knez I; Koestenberger M
    BMC Pediatr; 2020 May; 20(1):207. PubMed ID: 32393291
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical Presentation of Pediatric Patients at Risk for Sudden Cardiac Arrest.
    Dalal A; Czosek RJ; Kovach J; von Alvensleben JC; Valdes S; Etheridge SP; Ackerman MJ; Auld D; Huckaby J; McCracken C; Campbell R
    J Pediatr; 2016 Oct; 177():191-196. PubMed ID: 27502104
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hypertrophic cardiomyopathy and myocardial bridging.
    Achrafi H
    Int J Cardiol; 1992 Oct; 37(1):111-2. PubMed ID: 1428278
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Systolic compression of coronary artery in hypertrophic cardiomyopathy.
    Navarro-Lopez F; Soler J; Magriña J; Esplugues E; Pare JC; Sanz G; Betriu A
    Int J Cardiol; 1986 Sep; 12(3):309-20. PubMed ID: 3759268
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy.
    Dilsizian V; Bonow RO; Epstein SE; Fananapazir L
    J Am Coll Cardiol; 1993 Sep; 22(3):796-804. PubMed ID: 8102625
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of patients with hypertrophic cardiomyopathy at high risk for sudden death.
    Chang AC; McAreavey D; Fananapazir L
    Curr Opin Cardiol; 1995 Jan; 10(1):9-15. PubMed ID: 7787270
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study.
    Maron BJ; Savage DD; Wolfson JK; Epstein SE
    Am J Cardiol; 1981 Aug; 48(2):252-7. PubMed ID: 7196685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.